MARIA MOSSO: Open Payments
NPI 1679196570 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 52 payments from 12 companies in 2025. Trend: 2023 $424 · 2024 $1,922 · 2025 $1,062
Food & beverage: $952Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $285 |
| E.R. Squibb & Sons, L.L.C. | 5 | $189 |
| Teva Pharmaceuticals USA, Inc. | 3 | $158 |
| Corium, LLC | 4 | $110 |
| Tris Pharma Inc | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Noven Therapeutics, LLC | 3 | $49 |
| Lundbeck LLC | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
Products named: VRAYLAR, COBENFY, Azstarys, Dyanavel XR, CAPLYTA, Xelstrym, AUSTEDO XR, REXULTI.
Industry payments across TX — which companies pay providers there.
